MAIA BIOTECHNOLOGY INC.

NYSE: MAIA (MAIA Biotechnology, Inc.)

Last update: yesterday, 6:25PM

1.14

0.02 (1.79%)

Previous Close 1.12
Open 1.13
Volume 107,404
Avg. Volume (3M) 483,756
Market Cap 70,385,816
Price / Book 3.88
52 Weeks Range
0.870 (-23%) — 3.19 (179%)
Earnings Date 8 Aug 2025
Diluted EPS (TTM) -0.750
Current Ratio (MRQ) 2.35
Operating Cash Flow (TTM) -16.32 M
Levered Free Cash Flow (TTM) -10.01 M
Return on Assets (TTM) -111.96%
Return on Equity (TTM) -1,131.02%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock MAIA Biotechnology, Inc. - -

AIStockmoo Score

-1.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -2.5
Relative Valuation NA
Financial Health NA
AI Insight NA
Weighted Average -1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MAIA 70 M - - 3.88
CYBN 359 M - - 2.70
LCTX 252 M - - 3.97
PLX 205 M - 11.07 3.16
ARMP 114 M - - -
NRXS 96 M - - 13.64

Select this tab to load the latest available analysis.

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 23.33%
% Held by Institutions 4.09%

Ownership

Name Date Shares Held
Centric Wealth Management 30 Jun 2026 796,723
Bleakley Financial Group, Llc 30 Jun 2026 181,623

No data within this time range.

No data within this time range.

AI Technical Analysis

Open the Technical tab to generate the latest analysis.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria